$AXON

$10,000 in Axon Stock a Decade Ago Would Be Worth About $329,000 Today. The Stock Is Down Over the Past Year.

Axon Enterprise (AXON) shares rose sharply over the past decade, but are down over the past year and about 35% below a Aug. 7, 2025 record close of $870.97. After its Q2 report, the stock fell again. Q2 revenue rose 35% to $904M, with software up 36% and ARR $1.64B (+39%). Full-year revenue growth guidance was raised to 32% to 34%.

Original reporting
Published Aug 8, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
$10,000 in Axon Stock a Decade Ago Would Be Worth About $329,000 Today. The Stock Is Down Over the Past Year. — source image
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

Q2 results show strong top-line and recurring metrics, but the stock reaction is attributed to valuation sensitivity and a modest gross margin decline plus weaker GAAP earnings.

02

Market read

Traders may treat the move as a multiple reset risk rather than a fundamental growth break, while monitoring margin trajectory and earnings quality.

03

What to watch

The article emphasizes growth and bookings, but does not quantify cash flow, free-cash-flow conversion, or guidance assumptions that could explain the multiple reset.

Relevance 4/10Novelty 3/10Timing: after the company’s second-quarter report, shares slid again this week

Background

Axon transitioned from TASER hardware toward a software and subscription model tied to evidence storage and connected devices.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon shares slid after its Q2 report, despite 35% revenue growth, with adjusted gross margin down to 62.9% and GAAP net income of $29M.

Expected impact

Near-term volatility likely tied to multiple sensitivity; downside risk increases if margins keep slipping or growth falls below 30%.

Evidence & confidence

The newest concrete facts are Q2 growth (35%), margin (62.9%), and profitability (GAAP net income $29M vs adjusted $155M), which can justify a valuation reset even if growth remains strong.

Market effects

Reinforces that public-safety tech hardware-plus-subscription models can still trade like high-multiple software, making margins and earnings quality key.

No specific regional spillover beyond US-listed sentiment.

Limited, as the story is company-specific and US-focused.

Counterpoint

The margin dip and GAAP profitability gap may be more than a footnote; if professional services mix persists, the market may re-rate the subscription durability.

Key entities

  • Axon Enterprise

    Public-safety technology company whose Q2 report is cited as the catalyst for the stock’s recent slide.

Related articles

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.

$AXONMedAI 8/10

Axon Just Delivered a Huge Beat-and-Raise. So Why Is the Stock Down?

Axon Enterprise (AXON) reported Q2 revenue of $904 million, up 35% year over year, versus $876.5 million expected, with TASER revenue up 21% to $261.3 million. Adjusted EBITDA rose 40% to $242 million and adjusted EPS was $1.88. The company raised full-year revenue guidance to 32%-34% growth and maintained 25.5% adjusted EBITDA margin, but the stock fell after hours and during the session.

$AXONMed

Axon Enterprise Stock Slips After Q2 Earnings - Axon Enterprise (NASDAQ:AXON)

Axon Enterprise reported Q2 revenue of $904.39 million, above the $876.46 million estimate, and adjusted EPS of $1.88, above $1.85, according to Benzinga Pro. Software and Services revenue rose to $398 million and Connected Devices to $507 million. Annual recurring revenue increased to $1.6 billion. The company raised 2026 guidance to $3.67-$3.73 billion. Shares fell 6.32% after hours to $570.95.

$AXONMed

Axon posts lower quarterly gross margin on higher mix of services, new product scaling

Axon Enterprise reported lower Q2 gross margin, citing a higher mix of professional services and spending to scale new product offerings, according to Reuters. Adjusted gross margin in its software and services segment fell 3.8 points to 75.1%. Revenue rose to $904 million, above $877 million estimates, and adjusted EPS was $1.88 vs $1.85 expected. Shares fell over 6% after hours.

$AXONHighAI 9/10

AXON ENTERPRISE, INC. (AXON): Results of Operations and Financial Condition

AXON ENTERPRISE, INC. (AXON) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 axon-20260805xex991.htm EX-99.1 Document Exhibit 99.1 CONTACT: Investor Relations Axon Enterprise, Inc. IR@axon.com Axon reports Q2 2026 revenue of $904 million, up 35% year over year • Annual recurring revenue grows 39% to $1.6 billion; net revenue retention reaches 12